BDB018

· Eikon Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BDB018, covering 2025-11-12 to 2025-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors [Phase 1]

See pricing